Enterprise Financial Services Corp (EFSC)’s Alnylam Pharmaceuticals ALNY Stock Holding History

Enterprise Financial Services Corp (EFSC)’s Portfolio ALNY Stock Details ALNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-47	Closed	-$8K	–	430
2021 Q2	$8K	Buy	47 +13	+38%	+$1.9K	﹤0.01%	803
2021 Q1	$5K	Hold	34	–	–	﹤0.01%	910
2020 Q4	$5K	Buy	34 +6	+21%	+$801	﹤0.01%	868
2020 Q3	$4K	Hold	28	–	–	﹤0.01%	871
2020 Q2	$4K	Buy	28 +23	+460%	+$3.1K	﹤0.01%	877
2020 Q1	$1K	Buy	+5	New	+$577	﹤0.01%	1108
2018 Q4	–	Sell	-19	Closed	-$2K	–	980
2018 Q3	$2K	Buy	+19	New	+$1.91K	﹤0.01%	890
2017 Q2	–	Sell	-66	Closed	-$3K	–	930
2017 Q1	$3K	Buy	+66	New	+$3.05K	﹤0.01%	840
2016 Q1	–	Sell	-63	Closed	-$6K	–	1049
2015 Q4	$6K	Sell	63 -2	-3%	-$185	﹤0.01%	674
2015 Q3	$5K	Hold	65	–	–	﹤0.01%	690
2015 Q2	$8K	Buy	+65	New	+$7.77K	﹤0.01%	604

Other funds holding ALNY

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Enterprise Financial Services Corp (EFSC)'s ALNY Position: Q3 2021 in Review

Enterprise Financial Services Corp (EFSC) sold out of Alnylam Pharmaceuticals (ALNY) in Q3 2021, closing a stake of 47 shares — an estimated $8K sold.

Enterprise Financial Services Corp (EFSC) first reported a position in ALNY in Q2 2015 and held it in 11 quarters. The position peaked at $8K in Q2 2021. 405 funds tracked by Wall St. Rank hold ALNY as of Q3 2021.

Enterprise Financial Services Corp (EFSC) reported no remaining Alnylam Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
Enterprise Financial Services Corp (EFSC) sold 47 Alnylam Pharmaceuticals shares in Q3 2021, an estimated $8K.
Enterprise Financial Services Corp (EFSC) first reported a position in Alnylam Pharmaceuticals in Q2 2015 and held it in 11 quarters.
Enterprise Financial Services Corp (EFSC)'s Alnylam Pharmaceuticals position peaked at $8K in Q2 2021.
405 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q3 2021.

Based on Enterprise Financial Services Corp (EFSC)'s 13F filing for Q3 2021, filed 15 Nov 2021.